Donaldson, PolyPeptide to partner in peptide purification

The company states: “Donaldson Company and PolyPeptide Group AG announced their collaboration on the development of a production scale solvent recovery system for use in peptide purification. Peptides are used as the active pharmaceutical ingredient in therapeutic areas, which continue to broaden and include metabolic disorders, oncology, infectious diseases, orphan diseases, cardiovascular, neurology or gastro-enterology applications. The collaboration between Donaldson and PolyPeptide marks a milestone in the pharmaceutical industry’s pursuit of environmentally friendly manufacturing practices. By leveraging Donaldson’s experience in filtration and separation technologies and PolyPeptide’s expertise in peptide synthesis, the partnership aims to introduce a pioneering solution for reclaiming and purifying acetonitrile used in peptide purification. The technology is intended to be utilized for the benefit of the entire peptide manufacturing industry.”